{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:04:16Z","timestamp":1775063056523,"version":"3.50.1"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Aims\/Hypothesis<\/jats:title><jats:p>Large-scale prediabetes screening is still a challenge since fasting blood glucose and HbA<jats:sub>1c<\/jats:sub> as the long-standing, recommended analytes have only moderate diagnostic sensitivity, and the practicability of the oral glucose tolerance test for population-based strategies is limited. To tackle this issue and to identify reliable diagnostic patterns, we developed an innovative metabolomics-based strategy deviating from common concepts by employing urine instead of blood samples, searching for sex-specific biomarkers, and focusing on modified metabolites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Non-targeted, modification group-assisted metabolomics by liquid chromatography\u2013mass spectrometry (LC-MS) was applied to second morning urine samples of 340 individuals from a prediabetes cohort. Normal (<jats:italic>n<\/jats:italic> = 208) and impaired glucose-tolerant (IGT; <jats:italic>n<\/jats:italic> = 132) individuals, matched for age and BMI, were randomly divided in discovery and validation cohorts. ReliefF, a feature selection algorithm, was used to extract sex-specific diagnostic patterns of modified metabolites for the detection of IGT. The diagnostic performance was compared with conventional screening parameters fasting plasma glucose (FPG), HbA<jats:sub>1c<\/jats:sub>, and fasting insulin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Female- and male-specific diagnostic patterns were identified in urine. Only three biomarkers were identical in both. The patterns showed better AUC and diagnostic sensitivity for prediabetes screening of IGT than FPG, HbA<jats:sub>1c<\/jats:sub>, insulin, or a combination of FPG and HbA<jats:sub>1c<\/jats:sub>. The AUC of the male-specific pattern in the validation cohort was 0.889 with a diagnostic sensitivity of 92.6% and increased to an AUC of 0.977 in combination with HbA<jats:sub>1c<\/jats:sub>. In comparison, the AUCs of FPG, HbA<jats:sub>1c<\/jats:sub>, and insulin alone reached 0.573, 0.668, and 0.571, respectively. Validation of the diagnostic pattern of female subjects showed an AUC of 0.722, which still exceeded the AUCs of FPG, HbA<jats:sub>1c<\/jats:sub>, and insulin (0.595, 0.604, and 0.634, respectively). Modified metabolites in the urinary patterns include advanced glycation end products (pentosidine-glucuronide and glutamyl-lysine-sulfate) and microbiota-associated compounds (indoxyl sulfate and dihydroxyphenyl-gamma-valerolactone-glucuronide).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions\/Interpretation<\/jats:title><jats:p>Our results demonstrate that the sex-specific search for diagnostic metabolite biomarkers can be superior to common metabolomics strategies. The diagnostic performance for IGT detection was significantly better than routinely applied blood parameters. Together with recently developed fully automatic LC-MS systems, this opens up future perspectives for the application of sex-specific diagnostic patterns for prediabetes screening in urine.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.935016","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:49:51Z","timestamp":1657774191000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic Performance of Sex-Specific Modified Metabolite Patterns in Urine for Screening of Prediabetes"],"prefix":"10.3389","volume":"13","author":[{"given":"Zaifang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Hoene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"B1","volume-title":"Idf Diabetes Atlas","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109118","article-title":"Idf Diabetes Atlas: Global Estimates of Undiagnosed Diabetes in Adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)60283-9","article-title":"Prediabetes: A High-Risk State for Diabetes Development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108233","article-title":"Review of Methods for Detecting Glycemic Disorders","volume":"165","author":"Bergman","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6538","article-title":"Efficacy and Effectiveness of Screen and Treat Policies in Prevention of Type 2 Diabetes: Systematic Review and Meta-Analysis of Screening Tests and Interventions","volume":"356","author":"Barry","year":"2017","journal-title":"Bmj"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3158","article-title":"Standards of Medical Care for Type 2 Diabetes in China 2019","volume":"35","author":"Jia","year":"2019","journal-title":"Diabetes\/metabolism Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1410","article-title":"Performance of an A1c and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China","volume":"33","author":"Zhou","year":"2010","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12305","article-title":"Plasma Glucose and Hemoglobin A1c for the Detection of Diabetes in Chinese Adults","volume":"8","author":"Xu","year":"2016","journal-title":"J Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.235884","article-title":"Identification of Newly Diagnosed Diabetes and Prediabetes Using Fasting Plasma Glucose and Urinary Glucose in a Chinese Population: A Multicenter Cross-Sectional Study","volume":"131","author":"Chen","year":"2018","journal-title":"Chin Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12902-020-00653-x","article-title":"Metabolite Biomarkers of Type 2 Diabetes Mellitus and Pre-Diabetes: A Systematic Review and Meta-Analysis","volume":"20","author":"Long","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1705","article-title":"Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-Analysis of Prospective Cohort Studies","volume":"45","author":"Morze","year":"2022","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-010-0203-1","article-title":"Metabonomic Fingerprints of Fasting Plasma and Spot Urine Reveal Human Pre-Diabetic Metabolic Traits","volume":"6","author":"Zhao","year":"2010","journal-title":"Metabolomics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4851323","article-title":"Urinary Metabolomic Markers of Protein Glycation, Oxidation, and Nitration in Early-Stage Decline in Metabolic, Vascular, and Renal Health","volume":"2019","author":"Masania","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.250761","article-title":"Prospective Associations of Systemic and Urinary Choline Metabolites With Incident Type 2 Diabetes","volume":"62","author":"Svingen","year":"2016","journal-title":"Clin Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c01715","article-title":"Systematic, Modifying Group-Assisted Strategy Expanding Coverage of Metabolite Annotation in Liquid Chromatography-Mass Spectrometry-Based Nontargeted Metabolomics Studies","volume":"93","author":"Zheng","year":"2021","journal-title":"Anal Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1021\/ac502045j","article-title":"Nontargeted Modification-Specific Metabolomics Study Based on Liquid Chromatography-High-Resolution Mass Spectrometry","volume":"86","author":"Dai","year":"2014","journal-title":"Anal Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/ac050697c","article-title":"Measuring Fifteen Endogenous Estrogens Simultaneously in Human Urine by High-Performance Liquid Chromatography-Mass Spectrometry","volume":"77","author":"Xu","year":"2005","journal-title":"Anal Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5b00615","article-title":"Multiple Reaction Monitoring-Ion Pair Finder: A Systematic Approach to Transform Nontargeted Mode to Pseudotargeted Mode for Metabolomics Study Based on Liquid Chromatography-Mass Spectrometry","volume":"87","author":"Luo","year":"2015","journal-title":"Anal Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/A:1008280620621","article-title":"Overcoming the Myopia of Inductive Learning Algorithms With Relieff","volume":"7","author":"Kononenko","year":"1997","journal-title":"Appl Intell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2020.01.028","article-title":"Which Is the Urine Sample Material of Choice for Metabolomics-Driven Biomarker Studies","volume":"1105","author":"Liu","year":"2020","journal-title":"Anal Chim Acta"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-021-03450-0","article-title":"From Bedside to Bench-Practical Considerations to Avoid Pre-Analytical Pitfalls and Assess Sample Quality for High-Resolution Metabolomics and Lipidomics Analyses of Body Fluids","volume":"413","author":"Lehmann","year":"2021","journal-title":"Anal Bioanal Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1023\/A:1025667309714","article-title":"Theoretical and Empirical Analysis of Relieff and Rrelieff","volume":"53","author":"Robnik-\u0160ikonja","year":"2003","journal-title":"Mach Learn"},{"key":"B23","volume-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of Who\/Idf Consultation","year":"2006"},{"key":"B24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12916-021-02054-w","article-title":"Choice of Hba1c Threshold for Identifying Individuals at High Risk of Type 2 Diabetes and Implications for Diabetes Prevention Programmes: A Cohort Study","volume":"19","author":"Rodgers","year":"2021","journal-title":"BMC Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)60472-8","article-title":"Hba1c 5\u00b77-6\u00b74% and Impaired Fasting Plasma Glucose for Diagnosis of Prediabetes and Risk of Progression to Diabetes in Japan (Topics 3): A Longitudinal Cohort Study","volume":"378","author":"Heianza","year":"2011","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0679","article-title":"A1c Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (Iras)","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.732319","article-title":"Phospholipases and Reactive Oxygen Species Derived Lipid Biomarkers in Healthy and Diseased Humans and Animals - a Focus on Lysophosphatidylcholine","volume":"12","author":"Engel","year":"2021","journal-title":"Front Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01480-z","article-title":"Multifaceted Role of Branched-Chain Amino Acid Metabolism in Cancer","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64801","article-title":"2-Aminoadipic Acid Is a Biomarker for Diabetes Risk","volume":"123","author":"Wang","year":"2013","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/jci95995","article-title":"Dimethylguanidino Valeric Acid Is a Marker of Liver Fat and Predicts Diabetes","volume":"127","author":"O'Sullivan","year":"2017","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2307","article-title":"Metabolite Profiles and the Risk of Developing Diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4599-x","article-title":"Metabolomics Insights Into Early Type 2 Diabetes Pathogenesis and Detection in Individuals With Normal Fasting Glucose","volume":"61","author":"Merino","year":"2018","journal-title":"Diabetologia"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0707","article-title":"Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance","volume":"62","author":"Ferrannini","year":"2013","journal-title":"Diabetes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel Biomarkers for Pre-Diabetes Identified by Metabolomics","volume":"8","author":"Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-01104","article-title":"Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance","volume":"104","author":"Wildberg","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.09.028","article-title":"Association of Serum Metabolites With Impaired Fasting Glucose\/Diabetes and Traditional Risk Factors for Metabolic Disease in Chinese Adults","volume":"487","author":"Wang","year":"2018","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0495","article-title":"Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach","volume":"62","author":"Floegel","year":"2012","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.067827","article-title":"Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0236","article-title":"Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program","volume":"68","author":"Chen","year":"2019","journal-title":"Diabetes"},{"key":"B41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-Based Subphenotyping of Individuals at Elevated Risk for Type 2 Diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jbi.2018.07.014","article-title":"Relief-Based Feature Selection: Introduction and Review","volume":"85","author":"Urbanowicz","year":"2018","journal-title":"J BioMed Inform"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-015-0795-6","article-title":"Sex Differences in Urine Metabolites Related With Risk of Diabetes Using Nmr Spectroscopy: Results of the Study of Health in Pomerania","volume":"11","author":"Friedrich","year":"2015","journal-title":"Metabolomics"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1002\/9783527612505","volume-title":"Samples: From the Patient to the Laboratory","author":"Guder","year":"2003"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2018.03.087","article-title":"A High Throughput Metabolomics Method and Its Application in Female Serum Samples in a Normal Menstrual Cycle Based on Liquid Chromatography-Mass Spectrometry","volume":"185","author":"Ouyang","year":"2018","journal-title":"Talanta"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq011","article-title":"Effects of Menstrual Cycle Phase on Metabolomic Profiles in Premenopausal Women","volume":"25","author":"Wallace","year":"2010","journal-title":"Hum Reprod"},{"key":"B47","doi-asserted-by":"publisher","first-page":"14568","DOI":"10.1038\/s41598-018-32647-0","article-title":"Menstrual Cycle Rhythmicity: Metabolic Patterns in Healthy Women","volume":"8","author":"Draper","year":"2018","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141743","article-title":"Plasma Metabolic Profiles in Women Are Menopause Dependent","volume":"10","author":"Ke","year":"2015","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222353","article-title":"Differential Metabolomics Networks Analysis of Menopausal Status","volume":"14","author":"Cui","year":"2019","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1038\/ncomms5708","article-title":"A Metabolic View on Menopause and Ageing","volume":"5","author":"Auro","year":"2014","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.51.537","article-title":"Relationship Between Blood Levels of N-Carboxymethyl-Lysine and Pentosidine and the Severity of Microangiopathy in Type 2 Diabetes","volume":"51","author":"Hirata","year":"2004","journal-title":"Endocr J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-01061","article-title":"Nod1: An Interface Between Innate Immunity and Insulin Resistance","volume":"160","author":"Rivers","year":"2019","journal-title":"Endocrinology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ec-18-0450","article-title":"Sex Hormones, Obesity and Type 2 Diabetes: Is There a Link","volume":"8","author":"Gambineri","year":"2019","journal-title":"Endocr Connect"},{"key":"B55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jnutbio.2018.09.004","article-title":"Common Gut Microbial Metabolites of Dietary Flavonoids Exert Potent Protective Activities in B-Cells and Skeletal Muscle Cells","volume":"62","author":"Bitner","year":"2018","journal-title":"J Nutr Biochem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/0929867321666140916115519","article-title":"Procyanidins and Their Healthy Protective Effects Against Type 2 Diabetes","volume":"22","author":"Gonzalez-Abuin","year":"2015","journal-title":"Curr Med Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.09.053","article-title":"Serum Indoxyl Sulfate Levels in Patients With Diabetic Nephropathy: Relation to Renal Function","volume":"83","author":"Atoh","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.09.014","article-title":"High Serum Pentosidine Concentrations Are Associated With Increased Arterial Stiffness and Thickness in Patients With Type 2 Diabetes","volume":"54","author":"Yoshida","year":"2005","journal-title":"Metabolism"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.5.877","article-title":"Increased Serum Levels of Pentosidine, But Not Carboxymethyl Lysine, in Type 2 Diabetes Without Obvious Diabetic Nephropathy","volume":"22","author":"Daimon","year":"1999","journal-title":"Diabetes Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5301\/ejo.2010.4447","article-title":"Pentosidine and N-Carboxymethyl-Lysine: Biomarkers for Type 2 Diabetic Retinopathy","volume":"21","author":"Ghanem","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1159\/000078639","article-title":"Elevated Epsilon-(Gamma-Glutamyl)Lysine in Human Diabetic Nephropathy Results From Increased Expression and Cellular Release of Tissue Transglutaminase","volume":"97","author":"El Nahas","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1443","article-title":"Chronic Ingestion of Flavan-3-Ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year Cvd Risk in Medicated Postmenopausal Women With Type 2 Diabetes: A 1-Year, Double-Blind, Randomized, Controlled Trial","volume":"35","author":"Curtis","year":"2012","journal-title":"Diabetes Care"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/cells10061474","article-title":"Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity","volume":"10","author":"Mart\u00edn","year":"2021","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1772","article-title":"Polyphenols as Modulators of Pre-Established Gut Microbiota Dysbiosis: State-Of-the-Art","volume":"48","author":"Molinari","year":"2022","journal-title":"Biofactors"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.402","article-title":"Uremic Toxins Originating From Colonic Microbial Metabolism","author":"Evenepoel","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1900\/rds.2010.7.275","article-title":"Increased Levels of Total P-Cresylsulphate and Indoxyl Sulphate Are Associated With Coronary Artery Disease in Patients With Diabetic Nephropathy","volume":"7","author":"Chiu","year":"2010","journal-title":"Rev Diabetes Stud"},{"key":"B67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/bf01245022","article-title":"Urinary Mhpg Sulfate as a Marker of Central Norepinephrine Metabolism: A Commentary","volume":"80","author":"Peyrin","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1159\/000074887","article-title":"Blood Glucose Is Correlated With Cerebrospinal Fluid Neurotransmitter Metabolites","volume":"78","author":"Umhau","year":"2003","journal-title":"Neuroendocrinology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20614","article-title":"The Effects of Dietary Weight Loss on Indices of Norepinephrine Turnover: Modulatory Influence of Hyperinsulinemia","volume":"22","author":"Straznicky","year":"2014","journal-title":"Obes (Silver Spring)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0009-8981(72)90202-1","article-title":"The Occurrence of Adipic and Suberic Acid in Urine From Ketotic Patients","volume":"38","author":"Pettersen","year":"1972","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"B71","article-title":"Medium-Chain Acyl-Coenzyme a Dehydrogenase Deficiency","volume-title":"Genereviews","author":"Merritt","year":"2000"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/med.21293","article-title":"Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers","volume":"34","author":"Liu","year":"2014","journal-title":"Med Res Rev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-021-03813-7","article-title":"Data Analysis Methods for Defining Biomarkers From Omics Data","volume":"414","author":"Li","year":"2022","journal-title":"Anal Bioanal Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0848","article-title":"Evaluation of the First Immunosuppressive Drug Assay Available on a Fully Automated Lc-Ms\/Ms-Based Clinical Analyzer Suggests a New Era in Laboratory Medicine","volume":"59","author":"H\u00f6rber","year":"2021","journal-title":"Clin Chem Lab Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.935016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:49:57Z","timestamp":1657774197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.935016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":74,"alternative-id":["10.3389\/fendo.2022.935016"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.935016","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"935016"}}